 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Chiron Corporation
 |
Chiron Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
U.S. FDA raps Aventis, SkyePharma over drug claims Aug 07 2001 09:13 AM PDT
Chiron Q2 profits dip, 2001 outlook raised Jul 25 2001 01:17 PM PDT
Australian stocks dragged lower by miners, CPI Jul 24 2001 11:39 PM PDT
SkyePharma licenses cancer drug to Elan Jul 24 2001 11:38 PM PDT
Chiron sells meningitis vaccine to Quebec, shrs up Jul 18 2001 09:24 AM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
Planes, Loans and Automobiles
Nov 20 2000 12:00 AM PST
DNA Detectives
May 22 2000 12:00 AM PDT
Posts
Apr 17 2000 12:00 AM PDT
PROFILE |
 |
Chiron doesn't horse around when it comes to health. Named for a half-man/half-horse character from Greek mythology, Chiron focuses on developing biopharmaceuticals, vaccines, and blood testing devices. Its products target such diseases as AIDS, hepatitis, cardiovascular disease, and cancer. The company's flagship product, Proleukin, fights renal cancer and melanoma. Chiron makes most of its money from sales and licensing of existing products but is looking for its next blockbuster. The firm is working with Pharmacia to develop the first treatment for the potentially fatal infection sepsis. Novartis owns about 40% of the company.
COMPETITION |
 |
Abbott Laboratories (ABT)
Amgen Inc. (AMGN)
Merck & Co., Inc. (MRK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 972.10
1-Yr. Sales Growth: 27.5%
Employees: 3,422
Revenue per employee: $284,073.64
KEY PEOPLE |
 |
Sean P. Lance
CEO
James R. Sulat
CFO
CONTACT INFO |
 |
4560 Horton St.
Emeryville, CA 94608
US
Phone: 510-655-8730
Fax: 510-655-9910
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |